A new study from Oregon State University in the United States found that hops, the main ingredient of beer, can prevent prostate cancer and prostate hyperplasia.
However, researchers warned in the latest issue of Cancer Newsletter that people should not blindly "fill the refrigerator with beer" because the content of hops in beer is very low, and it takes more than 17 bottles to reach the "dose" that can play a role.
The anti-cancer component in hops is a flavonoid compound called xanthohumol, which plays an anti-cancer role by inhibiting a specific protein in prostate surface cells. This protein is like a "signal switch", which can "turn on" a variety of cancer cells in animals and humans, including prostate cancer.
It is reported that xanthohumol was isolated from hops as early as 1913, but its health effect was first proposed by Fred Stevens, assistant professor of Oregon State University, 10 years ago. In the fall of 2005, Stevens published a new research report on xanthohumol in the journal Phytochemistry, which attracted the attention of the international medical community.
Stevens suggested that the anti-cancer effect of xanthohumol should be paid attention to. Pharmaceutical companies can develop pills containing xanthohumol, and researchers can also increase the content of xanthohumol in hops. For example, German scientists have developed a new type of beer with xanthohumol content 10 times that of traditional beer.